Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$25.21 - $34.66 $1.04 Million - $1.43 Million
-41,263 Reduced 91.59%
3,790 $103,000
Q3 2023

Nov 13, 2023

BUY
$26.91 - $35.49 $1.21 Million - $1.6 Million
45,053 New
45,053 $1.34 Million
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $133,892 - $198,160
-7,651 Reduced 33.55%
15,154 $392,000
Q4 2022

Feb 14, 2023

SELL
$13.95 - $19.28 $75,553 - $104,420
-5,416 Reduced 19.19%
22,805 $409,000
Q3 2022

Nov 14, 2022

SELL
$14.66 - $18.3 $49,565 - $61,872
-3,381 Reduced 10.7%
28,221 $478,000
Q2 2022

Aug 15, 2022

BUY
$14.1 - $20.26 $445,588 - $640,256
31,602 New
31,602 $500,000

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.44B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.